Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis

被引:4
|
作者
Feng, Haoshen [1 ]
Yan, Lili [2 ]
Zhao, Yabin [3 ]
Li, Zhenhua [3 ]
Kang, Jian [3 ]
机构
[1] China Med Univ, Dept Pulm & Crit Care Med, Shengjing Hosp, Shenyang, Peoples R China
[2] Jinzhou Med Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Jinzhou, Peoples R China
[3] China Med Univ, Inst Resp Dis, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Shenyang, Peoples R China
基金
国家重点研发计划;
关键词
pulmonary sarcoidosis; neutrophils; bronchoalveolar lavage fluid; severity; relapse; MATRIX METALLOPROTEINASES; SEVERE ASTHMA; CELLS; TARGETS;
D O I
10.3389/fmed.2021.787681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary sarcoidosis is a highly heterogeneous granulomatous disease without any specific symptoms and manifestations. Neutrophils in bronchoalveolar lavage fluid (BALF) have been proposed to indicate the severity and prognosis of pulmonary sarcoidosis, but this needs confirmation in patients from different populations due to the heterogeneity of the disease. This study aimed to determine the characteristics of patients with pulmonary sarcoidosis in northeastern China and to explore the relationship between neutrophils in BALF and the severity of pulmonary sarcoidosis. MethodsWe enrolled 432 patients who were diagnosed with pulmonary sarcoidosis in this retrospective study. The symptoms, extrapulmonary involvement, forced vital capacity percentage predicted (FVC % pred), and diffusing capacity of the lung for carbon monoxide percentage predicted (DLco % pred) were recorded. BAL was performed in 319 patients, and the results of a cellular examination of BALF were collected. A total of 123 patients who received corticosteroid treatment were followed up for at least 12 months, and the outcomes were recorded. ResultsCough was the most common symptom, and cutaneous involvement was the most common extrapulmonary manifestation in 304 (70.4%) and 82 (19.0%) patients, respectively. The percentages of patients with high neutrophil counts in BALF (>3%) were higher at Stages 2 and 3 compared with Stages 0 and 1 (33.2 vs. 19.4%, p = 0.007), although the percentages of neutrophils in BALF showed no difference between patients at Stages 0, 1, 2, and 3. Patients with high neutrophil counts in BALF had lower FVC % pred compared with the other patients (79.5 +/- 18.2 vs. 84.9 +/- 14.5%, p = 0.025) and were prone to relapse after corticosteroids were tapered. High neutrophil counts in BALF were independently associated with relapse after corticosteroids were tapered in a binary logistic regression analysis (p = 0.027). ConclusionsPatients with pulmonary sarcoidosis lacked specific symptoms and manifestations. The neutrophil count in BALF could indicate the severity and outcomes of pulmonary sarcoidosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [2] CYTOKINES IN THE BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH ACTIVE PULMONARY SARCOIDOSIS
    GIRGIS, RE
    BASHA, MA
    MALIARIK, M
    POPOVICH, J
    IANNUZZI, MC
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (01) : 71 - 75
  • [3] BRONCHOALVEOLAR LAVAGE FLUID AND SERUM COMPLEMENT ACTIVITY IN PULMONARY SARCOIDOSIS
    LAMBRE, CR
    LEMAHO, S
    DIBELLA, G
    DECREMOUX, H
    ATASSI, K
    BIGNON, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 134 (02): : 238 - 242
  • [4] ANGIOTENSIN CONVERTING ENZYME IN BRONCHOALVEOLAR LAVAGE FLUID IN PULMONARY SARCOIDOSIS
    PERRINFAYOLLE, M
    PACHECO, Y
    HARF, R
    MONTAGNON, B
    BIOT, N
    THORAX, 1981, 36 (10) : 790 - 792
  • [5] Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?
    Drent, M
    Jacobs, JA
    de Vries, J
    Lamers, RJS
    Liem, IH
    Wouters, EFM
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (06) : 1338 - 1344
  • [6] Bronchoalveolar lavage( BAL) fluid enzymes in assessing activity and severity of sarcoidosis
    Babu, Ainapurapu B.
    Guleria, Randeep G.
    Sharma, Rajesh S.
    Lakshmi, R. L.
    CHEST, 2006, 130 (04) : 128S - 129S
  • [7] BRONCHOALVEOLAR LAVAGE CYTOLOGY IN PULMONARY SARCOIDOSIS
    ZAMAN, SS
    ELSHAMI, A
    GUPTA, PK
    ACTA CYTOLOGICA, 1995, 39 (06) : 1117 - 1123
  • [8] Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis
    Kriegova, Eva
    Melle, Christian
    Kolek, Vitezslav
    Hutyrova, Beata
    Mrazek, Frantisek
    Bleul, Annett
    du Bois, Roland M.
    von Eggeling, Ferdinand
    Petrek, Martin
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (10) : 1145 - 1154
  • [9] Increased Antifungal Antibodies in Bronchoalveolar Lavage Fluid and Serum in Pulmonary Sarcoidosis
    Suchankova, M.
    Paulovicova, E.
    Paulovicova, L.
    Majer, I.
    Tedlova, E.
    Novosadova, H.
    Tibenska, E.
    Tedla, M.
    Bucova, M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 81 (04) : 259 - 264
  • [10] Levels of Transferrin in Bronchoalveolar Lavage Fluid in Sarcoidosis
    Shigemura, Masahiko
    Nasuhara, Yasuyuki
    Konno, Satoshi
    Hattori, Takeshi
    Shimizu, Chikara
    Matsuno, Kazuhiko
    Nishimura, Masaharu
    LUNG, 2010, 188 (02) : 151 - 157